Skip to main content
Top
Published in: BMC Neurology 1/2013

Open Access 01-12-2013 | Research article

Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset

Authors: Osamu Kano, Konosuke Iwamoto, Hirono Ito, Yuji Kawase, Derek Cridebring, Ken Ikeda, Yasuo Iwasaki

Published in: BMC Neurology | Issue 1/2013

Login to get access

Abstract

Background

There have been several reports concerning the survival time after symptom onset in patients with amyotrophic lateral sclerosis (ALS). However, little is known about how the choice of physician (i.e., general practitioner, neurologist, etc.) may affect the time it takes for a diagnosis of ALS to be made.

Methods

We conducted a retrospective study, covering a 20-year period, comparing the type of physician first consulted by an ALS patient at the time of initial symptoms and the amount of time that elapsed to the final diagnosis of ALS. A total of 202 patients were diagnosed and stratified according to the onset of ALS symptoms (bulbar onset [BO] and limb onset [LO]). We noted the type of physician first seen by the patient. The diagnostic interval was calculated as the time between onset of symptoms and the final diagnosis of ALS.

Results

A total of 202 ALS patients were examined. Clinical BO and LO was observed in 78 (36.6%) and in 124 (61.4%) of these patients, respectively. The type of physician examining these patients at the first symptoms of disease was as follows (BO and LO): neurologist (38.5% and 25.8%), general practitioner (14.1% and 35.5%), orthopedist (12.8% and 35.5%), otolaryngologist (15.4% and 0%), and neurosurgeon (14.1% and 3.2%). Mean diagnostic interval (standard deviation) for patients with either set of symptoms was 13.1 (6.5) months; the diagnostic interval of patients with BO and LO was 9.2 (4.5) and 15.2 (7.7) months, respectively. ALS diagnosis in LO patients was delayed by more than 10 months when the patient first consulted an orthopedist rather than a neurologist.

Conclusion

More than 50% of the ALS patients included in this study did not visit a neurologist at the first symptoms of disease onset. The diagnosis of ALS was prolonged in LO patients visiting an orthopedist. We speculate that this increase in the diagnostic interval in LO patients visiting an orthopedist was due to a lack of bulbar symptoms in the early stages of this disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994, 124 (Suppl): 96-107.CrossRefPubMed Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994, 124 (Suppl): 96-107.CrossRefPubMed
2.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000, 1 (5): 293-299. 10.1080/146608200300079536.CrossRefPubMed Brooks BR, Miller RG, Swash M, Munsat TL: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000, 1 (5): 293-299. 10.1080/146608200300079536.CrossRefPubMed
3.
go back to reference Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996, 347 (9013): 1425-1431.CrossRefPubMed Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996, 347 (9013): 1425-1431.CrossRefPubMed
4.
go back to reference Chio A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D: Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology. 1999, 53 (5): 1123-1125. 10.1212/WNL.53.5.1123.CrossRefPubMed Chio A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D: Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology. 1999, 53 (5): 1123-1125. 10.1212/WNL.53.5.1123.CrossRefPubMed
5.
go back to reference Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ: Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003, 61 (2): 171-177. 10.1212/01.WNL.0000076182.13137.38.CrossRefPubMed Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ: Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003, 61 (2): 171-177. 10.1212/01.WNL.0000076182.13137.38.CrossRefPubMed
6.
go back to reference Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009, 73 (15): 1218-1226. 10.1212/WNL.0b013e3181bc0141.CrossRefPubMedPubMedCentral Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009, 73 (15): 1218-1226. 10.1212/WNL.0b013e3181bc0141.CrossRefPubMedPubMedCentral
7.
go back to reference Czaplinski A, Yen AA, Simpson EP, Appel SH: Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Arch Neurol. 2006, 63 (8): 1139-1143. 10.1001/archneur.63.8.1139.CrossRefPubMed Czaplinski A, Yen AA, Simpson EP, Appel SH: Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Arch Neurol. 2006, 63 (8): 1139-1143. 10.1001/archneur.63.8.1139.CrossRefPubMed
8.
go back to reference Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G: Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004, 5 (4): 208-212.CrossRefPubMed Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G: Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004, 5 (4): 208-212.CrossRefPubMed
9.
go back to reference Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ: Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002, 59 (2): 280-282. 10.1212/WNL.59.2.280.CrossRefPubMed Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ: Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002, 59 (2): 280-282. 10.1212/WNL.59.2.280.CrossRefPubMed
10.
go back to reference Iwasaki Y, Ikeda K, Kinoshita M: The diagnostic pathway in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001, 2 (3): 123-126. 10.1080/146608201753275571.CrossRefPubMed Iwasaki Y, Ikeda K, Kinoshita M: The diagnostic pathway in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001, 2 (3): 123-126. 10.1080/146608201753275571.CrossRefPubMed
11.
go back to reference Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K: The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci. 2010, 294 (1–2): 81-85.CrossRefPubMed Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K: The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci. 2010, 294 (1–2): 81-85.CrossRefPubMed
12.
go back to reference Forbes RB, Colville S, Cran GW, Swingler RJ: Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry. 2004, 75 (12): 1753-1755. 10.1136/jnnp.2003.024364.CrossRefPubMedPubMedCentral Forbes RB, Colville S, Cran GW, Swingler RJ: Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry. 2004, 75 (12): 1753-1755. 10.1136/jnnp.2003.024364.CrossRefPubMedPubMedCentral
13.
go back to reference Haverkamp LJ, Appel V, Appel SH: Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995, 118 (Pt 3): 707-719.CrossRefPubMed Haverkamp LJ, Appel V, Appel SH: Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995, 118 (Pt 3): 707-719.CrossRefPubMed
14.
go back to reference Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O, Kinoshita M: The diagnostic interval in amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2002, 104 (2): 87-89. 10.1016/S0303-8467(01)00188-3.CrossRefPubMed Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O, Kinoshita M: The diagnostic interval in amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2002, 104 (2): 87-89. 10.1016/S0303-8467(01)00188-3.CrossRefPubMed
15.
go back to reference Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O: Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003, 74 (9): 1258-1261. 10.1136/jnnp.74.9.1258.CrossRefPubMedPubMedCentral Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O: Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003, 74 (9): 1258-1261. 10.1136/jnnp.74.9.1258.CrossRefPubMedPubMedCentral
16.
go back to reference Kihira T, Yoshida S, Okamoto K, Kazimoto Y, Ookawa M, Hama K, Miwa H, Kondo T: Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci. 2008, 268 (1–2): 95-101.CrossRefPubMed Kihira T, Yoshida S, Okamoto K, Kazimoto Y, Ookawa M, Hama K, Miwa H, Kondo T: Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci. 2008, 268 (1–2): 95-101.CrossRefPubMed
17.
go back to reference Yoshor D, Klugh A, Appel SH, Haverkamp LJ: Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery. 2005, 57 (5): 984-989. 10.1227/01.NEU.0000180028.64385.d3. discussion 984–989CrossRefPubMed Yoshor D, Klugh A, Appel SH, Haverkamp LJ: Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery. 2005, 57 (5): 984-989. 10.1227/01.NEU.0000180028.64385.d3. discussion 984–989CrossRefPubMed
Metadata
Title
Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset
Authors
Osamu Kano
Konosuke Iwamoto
Hirono Ito
Yuji Kawase
Derek Cridebring
Ken Ikeda
Yasuo Iwasaki
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2013
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-13-19

Other articles of this Issue 1/2013

BMC Neurology 1/2013 Go to the issue